TipRanks
55% OFF
PC:VIROM

Virometix AG

Wagistrasse 14 Schlieren, 8952, CHhttps://www.virometix.com/Therapeutics

Virometix AG is a privately held biotechnology company developing a new generation of fully synthetic vaccines to elicit targeted and protective immune responses against infectious diseases and cancer. The company’s proprietary Synthetic Virus-Like Particle (SVLP) platform combines rational molecular design and chemical synthesis to rapidly generate optimized vaccine candidates with superior safety, efficacy, manufacturability, and stability profiles.

Leadership & Board

Current Number of Employees
17
Current LinkedIn Followers
1,380

Latest Estimated Valuation

Estimated Valuation
―
Total Amount Raised
$15M
Total Funding Rounds
1
Latest Funding Amount
$15M
Latest Funding Round
Investment
Post-Money Valuation
―

Employee Trend

Virometix AG had 17 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.

17Latest Employee Count
0(0.00%)Week-Over-Week Change
05101520Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026

Social Trend

Virometix AG had 1,380 followers as of October 12, 2026. The number of followers increased by 8 (0.58%) week-over-week.

1,380Latest Followers Count
8(0.58%)Week-Over-Week Change
05001,0001,5002,000Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Nov 13, 2025Investment$15.00M―

Similar Companies

A snapshot of private companies similar to Virometix AG, helping you discover and navigate related company profiles.

Related News and Analysis